BridgeBio have substantially improved this development of the new treatment for ATTR-CM, leveraging Attruby. Initial trial information indicates significant benefits for individuals diagnosed with a serious condition. https://attruby636876.ampblogs.com/company-progresses-cardiac-amyloidosis-therapy-using-the-drug-79086433